» Articles » PMID: 37493609

MHC Tetramers Specifically Identify High- and Low-avidity Donor-specific B Cells in Transplantation Tolerance and Rejection

Overview
Journal Transplantation
Specialty General Surgery
Date 2023 Jul 26
PMID 37493609
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although donor-specific antibody pre- and posttransplantation is routinely assessed, accurate quantification of memory alloreactive B cells that mediate recall antibody response remains challenging. Major histocompatibility complex (MHC) tetramers have been used to identify alloreactive B cells in mice and humans, but the specificity of this approach has not been rigorously assessed.

Methods: B-cell receptors from MHC tetramer-binding single B cells were expressed as mouse recombinant immunoglobulin G1 (rIgG1) monoclonal antibodies, and the specificity was assessed with a multiplex bead assay. Relative binding avidity of rIgG1 was measured by modified dilution series technique and surface plasmon resonance. Additionally, immunoglobulin heavy chain variable regions of 50 individual B-cell receptors were sequenced to analyze the rate of somatic hypermutation.

Results: The multiplex bead assay confirmed that expressed rIgG1 monoclonal antibodies were preferentially bound to bait MHC class II I-E d over control I-A d and I-A b tetramers. Furthermore, the dissociation constant 50 binding avidities of the rIgG1 ranged from 10 mM to 7 nM. The majority of tetramer-binding B cells were low avidity, and ~12.8% to 15.2% from naive and tolerant mice and 30.9% from acute rejecting mice were higher avidity (dissociation constant 50 <1 mM).

Conclusions: Collectively, these studies demonstrate that donor MHC tetramers, under stringent binding conditions with decoy self-MHC tetramers, can specifically identify a broad repertoire of donor-specific B cells under conditions of rejection and tolerance.

Citing Articles

Marginal Zone B Cells Are Necessary for the Formation of Anti-donor IgG After Allogeneic Sensitization.

Kallarakal M, Cohen G, Ibukun F, Krummey S Transplantation. 2024; 108(6):1357-1367.

PMID: 38361235 PMC: 11136604. DOI: 10.1097/TP.0000000000004931.

References
1.
Nguyen H, Park J, Kang S, Kim M . Surface plasmon resonance: a versatile technique for biosensor applications. Sensors (Basel). 2015; 15(5):10481-510. PMC: 4481982. DOI: 10.3390/s150510481. View

2.
Cherukuri A, Rothstein D . Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation. Curr Opin Organ Transplant. 2022; 27(5):385-391. PMC: 9474638. DOI: 10.1097/MOT.0000000000001010. View

3.
Blanchard-Rohner G, Galli G, Clutterbuck E, Pollard A . Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children. J Immunol Methods. 2010; 358(1-2):46-55. DOI: 10.1016/j.jim.2010.03.014. View

4.
Wehmeier C, Karahan G, Heidt S . HLA-specific memory B-cell detection in kidney transplantation: Insights and future challenges. Int J Immunogenet. 2020; 47(3):227-234. PMC: 7317812. DOI: 10.1111/iji.12493. View

5.
Yang J, Chen J, Young J, Wang Q, Yin D, Sciammas R . Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation. Transplantation. 2016; 100(8):1683-91. PMC: 4961602. DOI: 10.1097/TP.0000000000001253. View